MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
MeiraGTx Holdings plc Ordinary Shares

MGTX

#2386
MeiraGTx Holdings plc Ordinary Shares
7.5600
+0.67%
Sector:
Base:
Profit Currency:
Daily Range
7.5600
7.5600
Year Range
7.0000
9.7300
Daily Change
+0.67%
Monthly Change
-5.50%
6 month change
-13.60%
Year Change
-13.60%
Previous Close
7.5100
Open
7.5600
Bid
Ask
Low
7.5600
High
7.5600
Volume
45
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. MGTX
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

News

Zacks Zacks
TGTX MGTX
2 days ago, 14:55
TG Therapeutics (TGTX) Misses Q4 Earnings Estimates
Investing Investing
MGTX
2026.02.03
MeiraGTx stock rises on exclusive licensing deal with ZipBio for eye disease therapy
Investing Investing
MGTX
2026.02.03
MeiraGTx licenses ZipBio’s AI-designed therapies for geographic atrophy
Investing Investing
LLY MGTX
2025.11.19
Truist Securities raises Eli Lilly stock price target to $1,182 on obesity drug outlook
Investing Investing
LLY MGTX
2025.11.18
JPMorgan raises Eli Lilly stock price target to $1,150 on obesity drug outlook
Investing Investing
LLY MGTX
2025.11.14
MeiraGTx stock price target raised to $16 from $12 at RBC Capital
Investing Investing
MGTX
2025.11.13
MeiraGTx earnings missed by $0.13, revenue fell short of estimates
Zacks Zacks
MGTX TWST
2025.11.13
MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Lags Revenue Estimates
Investing Investing
LLY MGTX
2025.11.11
MeiraGTx stock price target raised to $30 by Piper Sandler on Eli Lilly deal
Zacks Zacks
VYGR MGTX
2025.11.10
Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates
Investing Investing
LLY MGTX
2025.11.10
Eli Lilly signs deal for MeiraGTx’s gene therapy for severe eye disease
Investing Investing
MGTX
2025.11.10
MeiraGTx and Lilly partner on gene therapy for blindness in $75m deal

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd